PDF FluFOBT implementation Guide
The American Cancer Society FluFOBT program is intended to assist community health centers in increasing colorectal cancer (CRC) screening.
The American Cancer Society FluFOBT program is intended to assist community health centers in increasing colorectal cancer (CRC) screening.
Surveillance data show American Indians and Alaska Natives (AI/AN) have higher rates of colorectal cancer incidence and mortality, lower screening rates, and are more often diagnosed at later stages than Whites in many regions of the U.S. Screening can lower incidence and mortality rates, prevent CRC with premalignant polyp removal, and increase survival through diagnosis at earlier stages.
We sought to develop and test low-literacy instructions for completing the fecal immunochemical test.
A Reference Guide for IHS and Tribal Healthcare Providers
Infographic explaining why it’s important to have colorectal cancer screening done.
An Action plan to implement four essential strategies for clinicians.
The objectives of this study were to describe, examine, and compare prevalence estimates of colorectal cancer (CRC) screening practices and to determine whether disparities exist for American Indians/Alaska Natives (AIANs) and blacks compared with whites.
Fecal immunochemical testing (FIT) is superior to guiac-based testing if we are looking for blood in stools, as it has better one-time colorectal cancer sensitivity and specificity and better patient acceptance.
The American Cancer Society estimates that in 2011 about 141,210 people will be diagnosed with colorectal cancer and about 49,380 people will die of the disease in the US.
Only half of eligible patients in the United States undergo colorectal cancer (CRC) screening as recommended. Hypothesizing that the medical philanthropy platform may be effective in improving access to CRC screening, we aimed to demonstrate the feasibility of a flexible sigmoidoscopy (FS)- based CRC screening “health fair” for uninsured patients.